Hillsdale Investment Management Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 182 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$4,240,298
+19.5%
699,719
+19.7%
0.34%
+15.5%
Q4 2023$3,548,637
+1827.9%
584,619
+1240.3%
0.29%
+1605.9%
Q3 2023$184,072
-89.4%
43,619
-94.9%
0.02%
-89.2%
Q3 2022$1,740,000
-36.5%
861,7160.0%0.16%
-28.3%
Q2 2022$2,740,000
-23.7%
861,7160.0%0.22%
-5.6%
Q1 2022$3,593,000
-13.8%
861,716
-0.9%
0.23%
-16.8%
Q4 2021$4,167,000
-10.6%
869,916
-0.3%
0.28%
-22.5%
Q3 2021$4,659,000
+15.6%
872,516
+10.9%
0.36%
+12.1%
Q2 2021$4,029,000
-2.0%
786,816
+28.7%
0.32%
-6.7%
Q1 2021$4,113,000611,2000.34%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders